LINC02653: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02653

NCBI ID: G101926942

LINC02653

Other Name(s): Long intergenic non-protein coding RNA 2653 | long intergenic non-protein coding RNA 2653

LINC02653: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC02653 is a long non-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to play a significant role in regulating gene expression, cell signaling, and chromatin structure. Its unique features, such as its long length and non-coding nature, make it an attractive candidate for exploring new avenues in biology research.

Drug Target Potential

The long non-coding RNA hypothesis is a growing area of research, with many studies suggesting that lncRNAs may play a critical role in the development and progression of various diseases. LINC02653 is one of these lncRNAs that has been shown to have significant functions in multiple organisms, including humans.

Several studies have demonstrated that LINC02653 functions as a negative regulator of the gene encoding the protein heat shock protein (Hsp70), which is involved in a variety of cellular processes, including stress response, DNA damage repair, and inflammation. These functions are crucial for maintaining cellular homeostasis and have been implicated in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Furthermore, LINC02653 has also been shown to play a critical role in regulating the expression of genes involved in cell adhesion, migration, and invasion. These genes are involved in the development of various types of cancer, including breast, ovarian, and prostate cancer.

Biomarker Potential

LINC02653 has also been identified as a potential biomarker for several diseases, including cancer. Its functions in regulating the expression of cancer-related genes have been shown to be altered in various types of cancer. For example, several studies have shown that LINC02653 is downregulated in various types of cancer, including breast, ovarian, and prostate cancer.

In addition, LINC02653 has also been shown to be involved in the regulation of cellular signaling pathways, which are critical for the development and progression of cancer. Its functions in regulating these pathways have been implicated in the development of various types of cancer, including breast, ovarian, and prostate cancer.

Conclusion

In conclusion, LINC02653 is a long non-coding RNA that has been identified as having significant functions in various organisms, including humans. Its unique features, such as its long length and non-coding nature, make it an attractive candidate for exploring new avenues in biology research. The functional roles of LINC02653 in regulating gene expression, cell signaling, and chromatin structure suggest that it may be a valuable drug target or biomarker for the development and treatment of various diseases. Further research is needed to fully understand the functions of LINC02653 and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 2653

The "LINC02653 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02653 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets